Hirata, S.; Echigo, H.; Munekane, M.; Mishiro, K.; Washiyama, K.; Fuchigami, T.; Wakabayashi, H.; Takahashi, K.; Kinuya, S.; Ogawa, K.
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics. Molecules 2025, 30, 2804.
https://doi.org/10.3390/molecules30132804
AMA Style
Hirata S, Echigo H, Munekane M, Mishiro K, Washiyama K, Fuchigami T, Wakabayashi H, Takahashi K, Kinuya S, Ogawa K.
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics. Molecules. 2025; 30(13):2804.
https://doi.org/10.3390/molecules30132804
Chicago/Turabian Style
Hirata, Saki, Hiroaki Echigo, Masayuki Munekane, Kenji Mishiro, Kohshin Washiyama, Takeshi Fuchigami, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, and Kazuma Ogawa.
2025. "Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics" Molecules 30, no. 13: 2804.
https://doi.org/10.3390/molecules30132804
APA Style
Hirata, S., Echigo, H., Munekane, M., Mishiro, K., Washiyama, K., Fuchigami, T., Wakabayashi, H., Takahashi, K., Kinuya, S., & Ogawa, K.
(2025). Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics. Molecules, 30(13), 2804.
https://doi.org/10.3390/molecules30132804